Fischer Medical Ventures Ltd — Important, 24-10-2025: Company Update

Fischer Medical Ventures received a monitoring agency report for the quarter ended September 30, detailing the utilization of funds from its preferential issue. The company raised 270.40 Cr so far from the preferential issue, which included equity shares and fully convertible warrants. Out of this, 250.41 Cr was used for growth objectives, specifically investments in wholly-owned subsidiaries for imaging technologies and preventive healthcare devices. An additional 19.99 Cr was allocated for general corporate purposes. The report confirms no deviation from the stated objects and that all received proceeds have been fully utilized, signifying progress on its strategic initiatives.